Free Trial
→ Elon's next millionaires start October 24? (From Behind the Markets) (Ad)tc pixel Free BXC Stock Alerts

BlueLinx (BXC) Financials

BlueLinx logo
$72.34 +1.36 (+1.91%)
Closing price 10/13/2026 03:59 PM Eastern
Extended Trading
$72.29 -0.05 (-0.07%)
As of 10/13/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for BlueLinx

Annual Income Statements for BlueLinx

This table shows BlueLinx's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
Net Income / (Loss) Attributable to Common Shareholders		 -12 16 63 -48 -18 81 296 296 49 53 0.22
Consolidated Net Income / (Loss)		 -12 16 63 -48 -18 81 296 296 49 53 0.22
Net Income / (Loss) Continuing Operations		 -12 16 63 -48 -18 81 296 296 49 53 0.22
Total Pre-Tax Income 		-11 17 9.59 -60 -22 95 394 395 82 71 0.13
Total Operating Income		 16 42 30 -13 35 142 438 439 138 88 32
Total Gross Profit		 222 227 231 332 357 478 778 833 527 489 452
Total Revenue		 1,917 1,881 1,816 2,863 2,637 3,097 4,277 4,450 3,136 2,953 2,954
Operating Revenue		 1,917 1,881 1,816 2,863 2,637 3,097 4,277 4,450 3,136 2,953 2,954
Total Cost of Revenue		 1,694 1,654 1,585 2,531 2,280 2,620 3,499 3,617 2,609 2,463 2,502
Operating Cost of Revenue		 1,694 1,654 1,585 2,531 2,280 2,620 3,499 3,617 2,609 2,463 2,502
Total Operating Expenses		 206 186 201 345 322 335 344 394 389 402 419
Selling, General & Admin Expense		 196 205 199 319 309 321 325 370 360 367 383
Depreciation Expense		 9.74 9.34 9.03 26 30 29 28 28 32 38 40
Other Operating Expenses / (Income)		 - - - - -3.96 -4.01 - - -3.93 -3.93 -3.93
Other Special Charges / (Income)		 0.00 -28 -6.70 0.00 -13 -11 -8.43 -0.14 0.00 -0.27 0.00
Total Other Income / (Expense), net		 -28 -24 -20 -47 -57 -47 -44 -44 -57 -17 -32
Interest & Investment Income		 - - - - - - - -42 -24 -19 -32
Other Income / (Expense), net		 -0.50 0.45 0.82 0.38 -2.54 0.25 1.31 -2.05 -33 2.48 0.00
Income Tax Expense		 0.15 1.12 -53 -12 -3.95 14 98 99 33 18 -0.09
Basic Earnings per Share		 ($1.32) $1.80 $6.96 ($5.21) ($1.89) $8.58 $30.80 $31.75 $5.40 $6.22 $0.02
Weighted Average Basic Shares Outstanding		 8.75M 8.91M 9.14M 9.34M 9.37M 9.47M 9.73M 9.06M 8.65M 8.29M 7.87M
Diluted Earnings per Share		 ($1.32) $1.77 $6.81 ($5.21) ($1.89) $8.55 $29.99 $31.51 $5.39 $6.19 $0.02
Weighted Average Diluted Shares Outstanding		 8.75M 8.91M 9.14M 9.34M 9.37M 9.47M 9.73M 9.06M 8.65M 8.29M 7.87M
Weighted Average Basic & Diluted Shares Outstanding		 8.75M 8.91M 9.14M 9.34M 9.37M 9.47M 9.73M 9.06M 8.65M 8.29M 7.87M

Quarterly Income Statements for BlueLinx

This table shows BlueLinx's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 1/3/2026 4/4/2026 7/4/2026
Net Income / (Loss) Attributable to Common Shareholders		 -18 17 14 16 5.27 2.81 4.31 1.66 -8.55 -1.46 6.41
Consolidated Net Income / (Loss)		 -18 17 14 16 5.27 2.81 4.31 1.66 -8.55 -1.46 6.41
Net Income / (Loss) Continuing Operations		 -18 17 14 16 5.27 2.81 4.31 1.66 -8.55 -1.46 6.41
Total Pre-Tax Income 		-8.02 23 19 22 6.97 4.14 6.58 1.36 -12 -1.82 11
Total Operating Income		 27 28 24 24 12 11 15 9.97 -3.24 7.33 21
Total Gross Profit		 118 128 122 126 113 111 120 108 113 116 140
Total Revenue		 713 726 768 747 711 709 780 749 716 731 814
Operating Revenue		 713 726 768 747 711 709 780 749 716 731 814
Total Cost of Revenue		 594 599 646 622 597 598 660 641 603 615 674
Operating Cost of Revenue		 594 599 646 622 597 598 660 641 603 615 674
Total Operating Expenses		 91 100 99 102 101 100 105 98 116 109 119
Selling, General & Admin Expense		 84 91 89 92 93 94 95 89 105 96 107
Depreciation Expense		 8.29 9.43 10 9.53 9.41 9.55 9.79 9.74 11 12 11
Other Operating Expenses / (Income)		 -0.98 -0.67 -0.98 -0.10 -0.98 -3.24 -0.40 -0.80 0.51 0.89 0.26
Total Other Income / (Expense), net		 -35 -4.62 -4.80 -2.39 -5.07 -6.58 -8.46 -8.60 -8.71 -9.15 -9.38
Interest & Investment Income		 - -4.62 -4.80 -4.62 - -6.58 -8.46 -8.60 -8.71 -9.15 -9.38
Income Tax Expense		 10 5.55 4.71 5.62 1.69 1.34 2.27 -0.29 -3.41 -0.36 4.82
Basic Earnings per Share		 ($1.98) $2.02 $1.65 $1.88 $0.67 $0.33 $0.54 $0.20 ($1.05) ($0.18) $0.82
Weighted Average Basic Shares Outstanding		 8.65M 8.66M 8.53M 8.38M 8.29M 8.02M 7.89M 7.87M 7.87M 7.78M 7.86M
Diluted Earnings per Share		 ($1.96) $2.00 $1.65 $1.87 $0.67 $0.33 $0.54 $0.20 ($1.05) ($0.18) $0.81
Weighted Average Diluted Shares Outstanding		 8.65M 8.66M 8.53M 8.38M 8.29M 8.02M 7.89M 7.87M 7.87M 7.78M 7.86M
Weighted Average Basic & Diluted Shares Outstanding		 8.65M 8.66M 8.53M 8.38M 8.29M 8.02M 7.89M 7.87M 7.87M 7.78M 7.86M

Annual Cash Flow Statements for BlueLinx

This table details how cash moves in and out of BlueLinx's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
Net Change in Cash & Equivalents		 0.29 0.73 -0.84 4.24 2.70 -12 85 214 223 -16 -120
Net Cash From Operating Activities		 40 41 -2.50 42 -10 55 145 400 306 85 60
Net Cash From Continuing Operating Activities		 40 41 -2.50 42 -10 55 145 400 306 85 60
Net Income / (Loss) Continuing Operations		 -12 16 63 -48 -18 81 296 296 49 53 0.22
Consolidated Net Income / (Loss)		 -12 16 63 -48 -18 81 296 296 49 53 0.22
Depreciation Expense		 9.74 9.34 9.03 26 30 29 28 28 32 38 40
Amortization Expense		 2.99 2.69 0.60 -2.19 3.32 3.88 -2.52 -2.78 1.32 1.32 1.51
Non-Cash Adjustments To Reconcile Net Income		 0.74 -24 -52 4.82 -15 -8.55 5.56 9.47 38 3.54 4.88
Changes in Operating Assets and Liabilities, net		 38 37 -23 61 -11 -50 -182 70 187 -11 13
Net Cash From Investing Activities		 -0.80 37 27 -243 21 9.16 -4.09 -99 -27 -39 -119
Net Cash From Continuing Investing Activities		 -0.80 37 27 -243 21 9.16 -4.09 -99 -27 -39 -119
Purchase of Property, Plant & Equipment		 -1.56 -0.63 -0.80 -2.72 -4.79 -3.69 -14 -36 -28 -40 -27
Acquisitions		 - 0.00 0.00 -348 - 0.00 0.00 -64 0.30 0.00 -95
Other Investing Activities, net		 - - - - - - - - 0.36 0.90 2.66
Net Cash From Financing Activities		 -39 -78 -25 205 -8.14 -76 -56 -88 -57 -62 -60
Net Cash From Continuing Financing Activities		 -39 -78 -25 205 -8.14 -76 -56 -88 -57 -62 -60
Repayment of Debt		 -447 -565 -468 -852 -693 -989 -335 - 0.00 0.00 -3.10
Repurchase of Common Equity		 - - - - - 0.00 0.00 -66 -42 -45 -38
Other Financing Activities, net		 -0.46 -0.18 -0.23 -3.02 35 69 -16 -21 -14 -17 -19
Cash Interest Paid		 24 21 20 37 47 44 33 44 43 45 47
Cash Income Taxes Paid		 0.69 0.63 1.58 2.64 2.99 14 99 111 19 30 3.99

Quarterly Cash Flow Statements for BlueLinx

This table details how cash moves in and out of BlueLinx's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 1/3/2026 4/4/2026 7/4/2026
Net Change in Cash & Equivalents		 52 -40 10 35 -21 -57 -62 43 -44 -67 -0.91
Net Cash From Operating Activities		 76 -31 36 62 19 -34 -27 59 62 -57 11
Net Cash From Continuing Operating Activities		 76 -31 36 62 19 -34 -27 59 62 -57 11
Net Income / (Loss) Continuing Operations		 -18 17 14 16 5.27 2.81 4.31 1.66 -8.55 -1.46 6.41
Consolidated Net Income / (Loss)		 -18 17 14 16 5.27 2.81 4.31 1.66 -8.55 -1.46 6.41
Depreciation Expense		 8.29 9.43 10 9.53 9.41 9.55 9.79 9.74 11 12 11
Amortization Expense		 -0.65 -0.65 -0.65 -0.65 -0.65 0.33 -0.65 -0.51 3.33 0.39 0.40
Non-Cash Adjustments To Reconcile Net Income		 32 2.35 1.41 0.96 2.76 -0.91 2.34 3.45 -1.00 2.11 2.26
Changes in Operating Assets and Liabilities, net		 54 -60 11 36 1.96 -46 -43 44 57 -70 -9.36
Net Cash From Investing Activities		 -8.12 -5.32 -6.31 -7.36 -20 -3.39 -9.54 -5.93 -101 -1.72 -2.32
Net Cash From Continuing Investing Activities		 -8.12 -5.32 -6.31 -7.36 -20 -3.39 -9.54 -5.93 -101 -1.72 -2.32
Purchase of Property, Plant & Equipment		 -8.58 -5.45 -6.45 -7.93 -20 -5.93 -9.61 -5.95 -5.45 -2.60 -2.38
Other Investing Activities, net		 - 0.13 - - - 2.54 0.07 0.02 0.03 0.02 0.07
Net Cash From Financing Activities		 -15 -3.98 -19 -20 -19 -19 -26 -10 -4.73 -7.81 -9.77
Net Cash From Continuing Financing Activities		 -15 -3.98 -19 -20 -19 -19 -26 -10 -4.73 -7.81 -9.77
Repayment of Debt		 - - - - - 0.00 - - -0.48 -0.13 -0.14
Repurchase of Common Equity		 -13 0.00 - -15 -15 -15 -20 -2.74 - -2.75 -2.58
Other Financing Activities, net		 -2.67 -3.98 -4.88 -4.06 -3.87 -4.30 -5.57 -4.74 -4.24 -4.93 -7.05
Cash Interest Paid		 15 6.80 15 6.88 16 7.16 16 7.16 17 7.13 16
Cash Income Taxes Paid		 1.56 1.34 21 2.13 6.18 -1.08 4.63 0.40 0.04 -0.05 0.39

Annual Balance Sheets for BlueLinx

This table presents BlueLinx's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
Total Assets		 513 444 494 960 971 1,048 1,317 1,490 1,538 1,578 1,549
Total Current Assets		 402 346 343 600 578 668 945 1,077 1,120 1,134 984
Cash & Equivalents		 4.81 5.54 4.70 8.94 12 0.08 85 299 522 506 386
Accounts Receivable		 139 126 134 208 193 294 340 252 228 226 218
Inventories, net		 227 191 188 342 346 342 488 484 344 356 326
Other Current Assets		 32 23 17 41 28 33 32 42 27 47 54
Plant, Property, & Equipment, net		 102 88 84 205 0.00 0.00 0.00 206 226 250 287
Plant, Property & Equipment, gross		 209 190 187 308 - - - - - - 495
Accumulated Depreciation		 107 102 103 103 - - - - - - 209
Total Noncurrent Assets		 9.54 10 67 155 393 380 372 208 191 194 278
Goodwill		 - - 0.00 48 48 48 48 55 55 55 67
Intangible Assets		 - - 0.00 35 26 19 14 35 31 27 87
Noncurrent Deferred & Refundable Income Taxes		 - 0.00 54 53 54 63 60 56 53 51 51
Other Noncurrent Operating Assets		 9.54 10 13 19 265 250 251 61 52 61 74
Total Liabilities & Shareholders' Equity		 513 444 494 960 971 1,048 1,317 1,490 1,538 1,578 1,549
Total Liabilities		 559 474 459 975 998 989 954 900 903 931 932
Total Current Liabilities		 130 154 118 197 171 229 244 211 219 234 211
Accounts Payable		 88 83 71 149 132 165 180 152 158 170 136
Current Deferred Revenue		 - - - - 3.94 4.04 3.93 3.94 3.94 3.94 3.94
Current Employee Benefit Liabilities		 4.17 8.35 9.23 7.97 7.64 25 22 23 14 17 17
Other Current Liabilities		 31 34 34 30 25 26 31 33 42 43 53
Total Noncurrent Liabilities		 429 320 341 778 826 760 710 689 685 698 721
Long-Term Debt		 378 271 277 498 458 321 291 292 294 295 297
Other Noncurrent Operating Liabilities		 14 14 9.96 24 345 416 408 397 391 402 424
Commitments & Contingencies		 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -46 -30 35 -15 -26 59 363 590 634 646 617
Total Preferred & Common Equity		 -46 -30 35 -15 -26 59 363 590 634 646 617
Preferred Stock		 - - - - - - - 0.00 0.00 0.00 0.00
Total Common Equity		 -46 -30 35 -15 -26 59 363 590 634 646 617
Common Stock		 256 258 260 259 261 267 268 201 165 124 95
Retained Earnings		 -267 -251 -188 -236 -253 -172 124 421 469 522 522

Quarterly Balance Sheets for BlueLinx

This table presents BlueLinx's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 4/1/2023 7/1/2023 9/30/2023 3/30/2024 6/29/2024 9/28/2024 3/29/2025 6/28/2025 9/27/2025 4/4/2026 7/4/2026
Total Assets		 1,526 1,550 1,585 1,592 1,586 1,611 1,633 1,584 1,582 1,598 1,604
Total Current Assets		 1,114 1,137 1,171 1,173 1,159 1,181 1,166 1,105 1,099 1,045 1,061
Cash & Equivalents		 376 418 470 481 491 526 449 387 429 319 318
Accounts Receivable		 299 294 298 288 274 278 276 279 269 297 316
Inventories, net		 409 379 364 371 358 341 400 391 346 372 375
Other Current Assets		 29 45 40 32 36 37 42 48 55 57 52
Plant, Property, & Equipment, net		 208 210 216 231 232 236 275 281 287 280 277
Plant, Property & Equipment, gross		 366 374 382 407 414 424 462 475 488 497 503
Accumulated Depreciation		 158 163 166 176 182 188 187 194 201 217 226
Total Noncurrent Assets		 204 203 199 188 195 194 192 198 196 274 265
Goodwill		 55 55 55 55 55 55 55 55 55 66 70
Intangible Assets		 34 33 32 30 29 28 26 25 24 85 79
Noncurrent Deferred & Refundable Income Taxes		 56 56 55 54 54 51 51 52 48 52 47
Other Noncurrent Operating Assets		 59 59 57 49 57 59 60 66 68 71 69
Total Liabilities & Shareholders' Equity		 1,526 1,550 1,585 1,592 1,586 1,611 1,633 1,584 1,582 1,598 1,604
Total Liabilities		 915 928 954 938 934 955 997 963 959 983 982
Total Current Liabilities		 228 245 268 249 237 258 281 243 239 268 265
Accounts Payable		 177 190 202 172 179 186 213 178 169 195 188
Current Deferred Revenue		 3.94 3.94 3.94 3.94 3.94 3.94 3.94 3.94 3.94 3.94 3.94
Current Employee Benefit Liabilities		 15 16 21 14 12 18 14 12 10 11 19
Other Current Liabilities		 32 34 41 60 42 49 50 48 56 58 53
Total Noncurrent Liabilities		 687 683 686 689 696 698 717 720 720 715 717
Long-Term Debt		 293 293 293 294 294 295 295 296 296 297 297
Other Noncurrent Operating Liabilities		 394 390 393 395 402 403 421 424 423 418 420
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 611 623 632 653 652 656 636 621 623 616 621
Total Preferred & Common Equity		 611 623 632 653 652 656 636 621 623 616 621
Preferred Stock		 - - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 611 623 632 653 652 656 636 621 623 616 621
Common Stock		 204 191 175 167 151 139 111 92 92 95 94
Retained Earnings		 438 463 487 487 501 517 525 529 531 521 527

Annual Metrics And Ratios for BlueLinx

This table displays calculated financial ratios and metrics derived from BlueLinx's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
DEI Shares Outstanding		 89,439,556.00 9,031,263.00 9,098,221.00 9,293,794.00 9,364,959.00 9,461,540.00 9,706,685.00 - - - 7,865,058.00
DEI Adjusted Shares Outstanding		 8,943,956.00 9,031,263.00 9,098,221.00 9,293,794.00 9,364,959.00 9,461,540.00 9,706,685.00 - - - 7,865,058.00
DEI Earnings Per Adjusted Shares Outstanding		 -1.29 1.78 6.92 -5.17 -1.89 8.55 30.51 - - - 0.03
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -3.17% -1.85% -3.48% 57.69% -7.88% 17.44% 38.09% 4.05% -29.52% -5.86% 0.05%
EBITDA Growth		 10.87% 88.95% -25.29% -73.46% 516.35% 164.91% 165.32% -0.69% -70.76% -6.77% -43.09%
EBIT Growth		 20.50% 164.49% -26.82% -141.89% 352.67% 336.97% 208.35% -0.53% -75.83% -14.75% -63.93%
NOPAT Growth		 21.28% 238.85% 406.15% -104.72% 364.59% 391.71% 172.20% 0.02% -75.09% -19.81% -16.20%
Net Income Growth		 16.55% 238.95% 291.63% -176.28% 63.26% 558.10% 266.13% 0.01% -83.61% 9.44% -99.59%
EPS Growth		 16.55% 234.09% 284.75% -176.51% 63.72% 552.38% 250.76% 5.07% -82.89% 14.84% -99.68%
Operating Cash Flow Growth		 424.58% 3.68% -106.05% 1,760.25% -124.80% 633.96% 163.59% 176.02% -23.49% -72.19% -29.81%
Free Cash Flow Firm Growth		 23.56% 168.01% 17.82% -405.19% 181.27% -48.41% -12.89% 122.79% -17.75% -86.04% -202.48%
Invested Capital Growth		 -7.92% -20.62% 26.48% 112.86% -40.70% -9.80% 49.25% 2.49% -30.37% 7.28% 21.16%
Revenue Q/Q Growth		 -1.34% -0.34% 0.66% 9.11% -2.19% 8.86% 2.58% -2.74% -4.13% -0.06% 0.18%
EBITDA Q/Q Growth		 33.57% 39.14% -22.15% -42.64% 17.93% 21.06% 19.01% -11.47% -29.37% 15.88% -11.79%
EBIT Q/Q Growth		 32.68% 44.05% -28.07% -692.75% 25.19% 27.91% 22.17% -12.29% -34.96% 21.83% -31.98%
NOPAT Q/Q Growth		 29.67% 1,156.77% 399.96% -508.61% 36.58% 27.31% 19.62% -11.43% -33.09% 20.05% 56.66%
Net Income Q/Q Growth		 12.00% 4,789.50% 216.97% -322.42% 25.29% 59.13% 22.18% -12.32% -50.80% 78.72% -98.44%
EPS Q/Q Growth		 12.00% 4,525.00% 212.39% -324.57% 25.59% 62.55% 20.78% -8.43% -54.36% 73.88% -98.85%
Operating Cash Flow Q/Q Growth		 -2.92% 4.13% -176.10% 276.70% -116.30% -45.91% 34.93% 51.51% -20.44% -40.01% 258.12%
Free Cash Flow Firm Q/Q Growth		 10.43% 12.49% 113.13% 26.72% 6.79% -24.83% 21.51% 22.70% -27.83% -57.85% -20.24%
Invested Capital Q/Q Growth		 -18.25% -14.20% 16.10% -12.58% -21.53% -8.71% -1.29% -15.65% -10.73% 2.79% 7.76%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 11.61% 12.09% 12.73% 11.59% 13.53% 15.42% 18.20% 18.72% 16.80% 16.57% 15.29%
EBITDA Margin		 1.49% 2.88% 2.23% 0.38% 2.51% 5.66% 10.87% 10.38% 4.31% 4.26% 2.50%
Operating Margin		 0.86% 2.21% 1.65% -0.46% 1.33% 4.59% 10.24% 9.87% 4.41% 2.97% 1.10%
EBIT Margin		 0.83% 2.24% 1.70% -0.45% 1.24% 4.60% 10.27% 9.82% 3.37% 3.05% 1.10%
Profit (Net Income) Margin		 -0.60% 0.86% 3.47% -1.68% -0.67% 2.61% 6.92% 6.66% 1.55% 1.80% 0.01%
Tax Burden Percent		 101.34% 93.48% 657.21% 79.81% 81.71% 85.07% 75.18% 75.03% 59.27% 75.14% 169.77%
Interest Burden Percent		 -71.76% 40.87% 31.11% 466.50% -66.26% 66.73% 89.64% 90.33% 77.52% 78.50% 0.40%
Effective Tax Rate		 0.00% 6.52% -557.21% 0.00% 0.00% 14.93% 24.82% 24.97% 40.73% 24.86% -69.77%
Return on Invested Capital (ROIC)		 3.30% 13.01% 65.71% -1.77% 4.33% 30.09% 69.28% 57.15% 16.58% 15.63% 11.44%
ROIC Less NNEP Spread (ROIC-NNEP)		 -2.63% 6.23% 20.61% -9.32% -2.85% 19.68% 56.71% 23.82% 45.17% 21.41% 48.09%
Return on Net Nonoperating Assets (RNNOA)		 24.96% -55.49% 2,375.45% -470.75% 82.33% 459.97% 70.95% 4.99% -8.65% -7.33% -11.41%
Return on Equity (ROE)		 28.26% -42.48% 2,441.15% -472.52% 86.66% 490.06% 140.23% 62.14% 7.93% 8.29% 0.03%
Cash Return on Invested Capital (CROIC)		 11.55% 36.00% 42.32% -73.92% 55.43% 40.39% 29.77% 54.69% 52.39% 8.60% -7.70%
Operating Return on Assets (OROA)		 3.03% 8.80% 6.57% -1.78% 3.38% 14.11% 37.15% 31.13% 6.98% 5.78% 2.08%
Return on Assets (ROA)		 -2.21% 3.36% 13.43% -6.61% -1.83% 8.01% 25.04% 21.10% 3.21% 3.41% 0.01%
Return on Common Equity (ROCE)		 28.26% -42.48% 2,441.15% -472.52% 86.66% 490.06% 140.23% 62.14% 7.93% 8.29% 0.03%
Return on Equity Simple (ROE_SIMPLE)		 25.22% -53.90% 179.97% 327.72% 67.69% 136.87% 81.52% 50.20% 7.65% 8.22% 0.00%
Net Operating Profit after Tax (NOPAT)		 11 39 197 -9.30 25 121 329 329 82 66 55
NOPAT Margin		 0.60% 2.07% 10.86% -0.32% 0.93% 3.91% 7.70% 7.40% 2.62% 2.23% 1.87%
Net Nonoperating Expense Percent (NNEP)		 5.93% 6.78% 45.09% 7.54% 7.18% 10.40% 12.58% 33.33% -28.59% -5.79% -36.65%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 37.33% 8.84% 6.99% 6.03%
Cost of Revenue to Revenue		 88.39% 87.91% 87.27% 88.41% 86.47% 84.58% 81.80% 81.28% 83.20% 83.43% 84.71%
SG&A Expenses to Revenue		 10.24% 10.87% 10.94% 11.15% 11.70% 10.37% 7.59% 8.32% 11.49% 12.44% 12.97%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 10.75% 9.88% 11.07% 12.06% 12.20% 10.83% 8.05% 8.85% 12.39% 13.60% 14.19%
Earnings before Interest and Taxes (EBIT)		 16 42 31 -13 33 142 439 437 106 90 32
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 29 54 40 11 66 175 465 462 135 126 74
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 2.54 0.00 0.00 4.69 2.56 1.09 1.57 1.34 0.77
Price to Tangible Book Value (P/TBV)		 0.00 0.00 2.54 0.00 0.00 0.00 3.08 1.29 1.81 1.54 1.03
Price to Revenue (P/Rev)		 0.02 0.04 0.05 0.08 0.05 0.09 0.22 0.14 0.32 0.29 0.16
Price to Earnings (P/E)		 0.00 4.19 1.41 0.00 0.00 3.42 3.14 2.17 20.47 16.37 2,181.75
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 23.84% 70.94% 0.00% 0.00% 29.22% 31.86% 46.10% 4.89% 6.11% 0.05%
Enterprise Value to Invested Capital (EV/IC)		 1.28 1.37 1.16 1.35 1.35 1.57 1.99 1.09 1.88 1.51 0.74
Enterprise Value to Revenue (EV/Rev)		 0.22 0.19 0.21 0.34 0.22 0.19 0.27 0.14 0.24 0.22 0.13
Enterprise Value to EBITDA (EV/EBITDA)		 14.90 6.69 9.61 89.71 8.65 3.42 2.44 1.38 5.67 5.23 5.26
Enterprise Value to EBIT (EV/EBIT)		 26.82 8.60 12.62 0.00 17.54 4.21 2.58 1.46 7.25 7.31 11.96
Enterprise Value to NOPAT (EV/NOPAT)		 37.16 9.30 1.97 0.00 23.25 4.95 3.45 1.93 9.33 10.01 7.05
Enterprise Value to Operating Cash Flow (EV/OCF)		 10.69 8.75 0.00 23.17 0.00 10.89 7.83 1.59 2.50 7.73 6.50
Enterprise Value to Free Cash Flow (EV/FCFF)		 10.62 3.36 3.06 0.00 1.82 3.69 8.03 2.02 2.95 18.19 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 -8.38 -10.06 8.71 -50.24 -17.66 5.46 0.80 0.50 0.46 0.46 0.48
Long-Term Debt to Equity		 -8.23 -9.07 8.60 -49.61 -17.58 5.44 0.80 0.50 0.46 0.46 0.48
Financial Leverage		 -9.50 -8.90 115.24 50.53 -28.88 23.37 1.25 0.21 -0.19 -0.34 -0.24
Leverage Ratio		 -12.81 -12.64 181.79 71.49 -47.40 61.18 5.60 2.95 2.47 2.43 2.47
Compound Leverage Factor		 9.19 -5.17 56.56 333.49 31.41 40.82 5.02 2.66 1.92 1.91 0.01
Debt to Total Capital		 113.56% 111.04% 89.70% 102.03% 106.00% 84.51% 44.50% 33.14% 31.65% 31.34% 32.46%
Short-Term Debt to Total Capital		 1.95% 10.90% 1.05% 1.29% 0.50% 0.31% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 111.61% 100.14% 88.65% 100.74% 105.50% 84.21% 44.50% 33.14% 31.65% 31.34% 32.46%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 -13.56% -11.04% 10.30% -2.03% -6.00% 15.49% 55.50% 66.86% 68.35% 68.66% 67.54%
Debt to EBITDA		 13.42 5.55 7.53 68.63 6.96 1.84 0.63 0.63 2.17 2.34 4.01
Net Debt to EBITDA		 13.25 5.44 7.42 67.80 6.79 1.84 0.44 -0.01 -1.69 -1.67 -1.21
Long-Term Debt to EBITDA		 13.19 5.00 7.45 67.76 6.93 1.83 0.63 0.63 2.17 2.34 4.01
Debt to NOPAT		 33.45 7.71 1.55 -79.22 18.72 2.66 0.88 0.89 3.58 4.48 5.38
Net Debt to NOPAT		 33.03 7.57 1.52 -78.26 18.25 2.66 0.63 -0.02 -2.78 -3.20 -1.62
Long-Term Debt to NOPAT		 32.88 6.95 1.53 -78.22 18.63 2.66 0.88 0.89 3.58 4.48 5.38
Altman Z-Score		 3.80 4.36 4.01 3.24 3.04 3.85 5.70 5.48 4.06 3.77 3.35
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.09 2.24 2.92 3.05 3.38 2.92 3.88 5.11 5.13 4.85 4.66
Quick Ratio		 1.10 0.85 1.18 1.10 1.20 1.28 1.74 2.61 3.43 3.13 2.86
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 40 108 127 -387 315 162 141 315 259 36 -37
Operating Cash Flow to CapEx		 4,984.64% 0.00% 0.00% 0.00% 0.00% 0.00% 3,547.53% 1,146.26% 1,127.58% 217.24% 221.97%
Free Cash Flow to Firm to Interest Expense		 1.47 4.33 5.98 -8.19 5.81 3.43 3.11 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 1.46 1.66 -0.12 0.88 -0.19 1.16 3.19 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 1.43 3.14 1.15 3.11 0.09 1.35 3.10 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 3.65 3.93 3.87 3.94 2.73 3.07 3.62 3.17 2.07 1.90 1.89
Accounts Receivable Turnover		 13.54 14.23 13.97 16.72 13.14 12.73 13.51 15.06 13.07 13.00 13.31
Inventory Turnover		 7.22 7.91 8.37 9.56 6.63 7.62 8.43 7.44 6.30 7.04 7.34
Fixed Asset Turnover		 18.53 19.81 21.10 19.82 0.00 0.00 0.00 0.00 14.53 12.42 11.02
Accounts Payable Turnover		 21.81 19.36 20.66 23.03 16.20 17.61 20.27 21.82 16.86 15.01 16.32
Days Sales Outstanding (DSO)		 26.96 25.65 26.13 21.83 27.77 28.67 27.02 24.24 27.93 28.08 27.43
Days Inventory Outstanding (DIO)		 50.55 46.13 43.63 38.17 55.03 47.93 43.32 49.08 57.91 51.83 49.73
Days Payable Outstanding (DPO)		 16.74 18.85 17.66 15.85 22.53 20.73 18.00 16.73 21.65 24.31 22.36
Cash Conversion Cycle (CCC)		 60.76 52.93 52.09 44.15 60.27 55.86 52.34 56.59 64.18 55.59 54.80
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 334 265 335 713 423 381 569 584 406 436 528
Invested Capital Turnover		 5.51 6.29 6.05 5.46 4.64 7.70 9.00 7.72 6.34 7.01 6.13
Increase / (Decrease) in Invested Capital		 -29 -69 70 378 -290 -41 188 14 -177 30 92
Enterprise Value (EV)		 427 362 389 963 572 599 1,136 636 765 659 389
Market Capitalization		 47 67 89 235 123 277 930 643 993 869 478
Book Value per Share		 ($0.51) ($3.30) $3.85 ($1.58) ($2.79) $6.25 $37.42 $65.30 $72.35 $77.13 $78.49
Tangible Book Value per Share		 ($0.51) ($3.30) $3.85 ($10.51) ($10.70) ($0.80) $31.10 $55.30 $62.52 $67.32 $58.92
Total Capital		 338 270 340 722 435 382 655 882 928 942 914
Total Debt		 384 300 305 737 461 322 291 292 294 295 297
Total Long-Term Debt		 378 271 301 727 458 321 291 292 294 295 297
Net Debt		 380 295 300 728 449 322 206 -6.52 -228 -211 -89
Capital Expenditures (CapEx)		 0.80 -37 -27 -105 -15 -9.16 4.09 35 27 39 27
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 274 215 225 403 397 440 616 567 380 395 387
Debt-free Net Working Capital (DFNWC)		 278 221 229 412 409 441 701 866 902 900 773
Net Working Capital (NWC)		 272 191 226 403 407 439 701 866 902 900 773
Net Nonoperating Expense (NNE)		 23 23 134 39 42 40 33 33 34 13 55
Net Nonoperating Obligations (NNO)		 380 295 300 728 449 322 206 -6.52 -228 -211 -89
Total Depreciation and Amortization (D&A)		 13 12 9.63 24 34 33 26 25 29 36 41
Debt-free, Cash-free Net Working Capital to Revenue		 14.28% 11.45% 12.37% 14.09% 15.07% 14.22% 14.41% 12.75% 12.12% 13.37% 13.11%
Debt-free Net Working Capital to Revenue		 14.53% 11.75% 12.63% 14.40% 15.51% 14.22% 16.40% 19.47% 28.75% 30.49% 26.17%
Net Working Capital to Revenue		 14.18% 10.18% 12.44% 14.08% 15.43% 14.19% 16.40% 19.47% 28.75% 30.49% 26.17%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($1.30) $1.80 $6.96 ($5.21) ($1.89) $8.58 $30.80 $31.75 $5.40 $6.22 $0.02
Adjusted Weighted Average Basic Shares Outstanding		 9.01M 9.01M 9.14M 9.34M 9.37M 9.47M 9.73M 9.06M 8.65M 8.29M 7.87M
Adjusted Diluted Earnings per Share		 ($1.30) $1.77 $6.81 ($5.21) ($1.89) $8.55 $29.99 $31.51 $5.39 $6.19 $0.02
Adjusted Weighted Average Diluted Shares Outstanding		 9.01M 9.01M 9.14M 9.34M 9.37M 9.47M 9.73M 9.06M 8.65M 8.29M 7.87M
Adjusted Basic & Diluted Earnings per Share		 ($1.30) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 8.75M 9.01M 9.14M 9.34M 9.37M 9.47M 9.73M 9.06M 8.65M 8.29M 7.87M
Normalized Net Operating Profit after Tax (NOPAT)		 11 13 16 -9.30 15 112 323 329 82 66 23
Normalized NOPAT Margin		 0.60% 0.67% 0.90% -0.32% 0.59% 3.62% 7.55% 7.40% 2.62% 2.22% 0.77%
Pre Tax Income Margin		 -0.60% 0.91% 0.53% -2.10% -0.82% 3.07% 9.21% 8.87% 2.61% 2.39% 0.00%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.58 1.69 1.45 -0.27 0.60 3.01 9.66 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.42 1.56 9.29 -0.20 0.45 2.55 7.24 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.55 3.17 2.72 1.95 0.88 3.20 9.57 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.39 3.04 10.55 2.03 0.73 2.75 7.15 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 22.43% 86.81% 85.28% 17,409.13%

Quarterly Metrics And Ratios for BlueLinx

This table displays calculated financial ratios and metrics derived from BlueLinx's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 1/3/2026 4/4/2026 7/4/2026
DEI Shares Outstanding		 - - - - - - 8,022,223.00 7,892,416.00 7,865,058.00 7,866,824.00 7,782,395.00
DEI Adjusted Shares Outstanding		 - - - - - - 8,022,223.00 7,892,416.00 7,865,058.00 7,866,824.00 7,782,395.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - 0.54 0.21 -1.09 -0.19 0.82
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -15.95% -8.98% -5.83% -7.74% -0.27% -2.34% 1.53% 0.21% 0.73% 3.09% 4.35%
EBITDA Growth		 -93.49% -6.51% -27.26% -24.45% 456.07% -46.15% -27.44% -45.35% -55.89% -4.46% 29.09%
EBIT Growth		 -107.53% -13.32% -38.06% -32.80% 419.09% -61.24% -36.95% -62.04% -126.95% -31.67% 37.03%
NOPAT Growth		 -52.63% -12.12% -39.59% -38.40% -52.15% -65.44% -45.12% -31.97% -124.92% -29.33% 19.37%
Net Income Growth		 -156.66% -1.80% -41.40% -34.31% 129.09% -83.96% -69.94% -89.67% -262.20% -151.98% 48.63%
EPS Growth		 -143.95% 3.09% -38.89% -31.00% 134.18% -83.50% -67.27% -89.30% -256.72% -154.55% 50.00%
Operating Cash Flow Growth		 -51.02% -135.00% -44.19% -20.41% -75.19% -8.91% -174.74% -5.10% 229.89% -68.77% 141.77%
Free Cash Flow Firm Growth		 655.55% -60.04% -79.34% -81.59% -110.44% -111.23% -208.22% -210.37% -361.35% -1,043.75% 10.32%
Invested Capital Growth		 -30.37% -11.62% -8.48% -6.83% 7.28% 3.54% 16.46% 15.58% 21.16% 22.97% 13.22%
Revenue Q/Q Growth		 -12.03% 1.92% 5.80% -2.74% -4.90% -0.20% 9.99% -4.00% -4.42% 2.14% 11.34%
EBITDA Q/Q Growth		 -91.86% 863.44% -8.60% 5.45% -40.11% -6.70% 23.16% -20.58% -43.20% 80.60% 64.91%
EBIT Q/Q Growth		 -109.86% 818.65% -13.81% 10.08% -53.20% -12.71% 40.20% -33.71% -132.53% 326.03% 181.15%
NOPAT Q/Q Growth		 -34.10% 10.37% -14.53% -0.90% -48.81% -20.28% 35.71% 22.84% -118.75% 326.03% 129.24%
Net Income Q/Q Growth		 -174.33% 196.51% -18.04% 11.72% -67.08% -46.79% 53.65% -61.60% -616.68% 82.95% 539.37%
EPS Q/Q Growth		 -172.32% 202.04% -17.50% 13.33% -64.17% -50.75% 63.64% -62.96% -625.00% 82.86% 550.00%
Operating Cash Flow Q/Q Growth		 -2.64% -141.21% 214.99% 72.52% -69.65% -280.90% 21.09% 319.06% 5.49% -192.55% 119.53%
Free Cash Flow Firm Q/Q Growth		 -26.09% -58.07% -26.92% -18.70% -141.91% 54.89% -604.05% 17.08% -75.17% -11.85% 44.80%
Invested Capital Q/Q Growth		 -10.73% 14.69% -2.28% -6.87% 2.79% 10.69% 9.90% -7.58% 7.76% 12.35% 1.19%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 16.62% 17.58% 15.94% 16.82% 15.95% 15.67% 15.34% 14.45% 15.73% 15.92% 17.16%
EBITDA Margin		 0.53% 5.02% 4.34% 4.70% 2.96% 2.77% 3.10% 2.56% 1.52% 2.69% 3.99%
Operating Margin		 3.82% 3.81% 3.10% 3.22% 1.69% 1.51% 1.93% 1.33% -0.45% 1.00% 2.53%
EBIT Margin		 -0.54% 3.81% 3.10% 3.51% 1.73% 1.51% 1.93% 1.33% -0.45% 1.00% 2.53%
Profit (Net Income) Margin		 -2.54% 2.41% 1.87% 2.14% 0.74% 0.40% 0.55% 0.22% -1.19% -0.20% 0.79%
Tax Burden Percent		 225.96% 75.91% 75.27% 74.04% 75.69% 67.69% 65.52% 121.42% 71.52% 80.15% 57.07%
Interest Burden Percent		 208.34% 83.29% 79.87% 82.40% 56.70% 38.64% 43.75% 13.68% 368.78% -24.82% 54.48%
Effective Tax Rate		 0.00% 24.09% 24.73% 25.96% 24.31% 32.31% 34.48% -21.42% 0.00% 0.00% 42.93%
Return on Invested Capital (ROIC)		 16.93% 17.85% 14.79% 16.00% 8.98% 6.34% 7.55% 10.43% -1.94% 3.88% 7.69%
ROIC Less NNEP Spread (ROIC-NNEP)		 48.61% 20.44% 17.04% 16.87% 10.73% 8.95% 11.40% 16.16% 2.25% 11.37% 17.24%
Return on Net Nonoperating Assets (RNNOA)		 -9.31% -4.38% -4.31% -5.35% -3.68% -2.37% -2.58% -4.61% -0.53% -1.60% -1.56%
Return on Equity (ROE)		 7.61% 13.47% 10.49% 10.65% 5.31% 3.97% 4.97% 5.82% -2.48% 2.28% 6.14%
Cash Return on Invested Capital (CROIC)		 52.39% 28.41% 22.86% 19.54% 8.60% 7.57% -6.14% -6.75% -7.70% -16.82% -8.11%
Operating Return on Assets (OROA)		 -1.12% 7.49% 5.97% 6.49% 3.28% 2.75% 3.58% 2.46% -0.86% 1.85% 4.78%
Return on Assets (ROA)		 -5.27% 4.74% 3.59% 3.96% 1.41% 0.72% 1.03% 0.41% -2.26% -0.37% 1.49%
Return on Common Equity (ROCE)		 7.61% 13.47% 10.49% 10.65% 5.31% 3.97% 4.97% 5.82% -2.48% 2.28% 6.14%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 7.38% 5.84% 4.53% 0.00% 6.04% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 19 21 18 18 9.11 7.26 9.85 12 -2.27 5.13 12
NOPAT Margin		 2.67% 2.89% 2.34% 2.38% 1.28% 1.02% 1.26% 1.62% -0.32% 0.70% 1.44%
Net Nonoperating Expense Percent (NNEP)		 -31.68% -2.59% -2.24% -0.87% -1.75% -2.61% -3.85% -5.73% -4.19% -7.49% -9.55%
Return On Investment Capital (ROIC_SIMPLE)		 2.05% - - - 0.97% 0.78% 1.07% 1.32% -0.25% 0.56% 1.28%
Cost of Revenue to Revenue		 83.38% 82.42% 84.06% 83.18% 84.05% 84.33% 84.66% 85.55% 84.27% 84.08% 82.84%
SG&A Expenses to Revenue		 11.78% 12.61% 11.64% 12.46% 13.11% 13.27% 12.21% 11.92% 14.60% 13.16% 13.19%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 12.81% 13.77% 12.83% 13.60% 14.26% 14.16% 13.42% 13.12% 16.19% 14.92% 14.63%
Earnings before Interest and Taxes (EBIT)		 -3.85 28 24 26 12 11 15 9.97 -3.24 7.33 21
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 3.78 36 33 35 21 20 24 19 11 20 32
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.57 1.75 1.24 1.36 1.34 1.00 0.96 0.94 0.77 0.66 0.71
Price to Tangible Book Value (P/TBV)		 1.81 2.01 1.42 1.56 1.54 1.15 1.10 1.08 1.03 0.87 0.94
Price to Revenue (P/Rev)		 0.32 0.37 0.27 0.30 0.29 0.22 0.20 0.20 0.16 0.14 0.15
Price to Earnings (P/E)		 20.47 23.68 21.17 29.99 16.37 16.54 20.97 41.64 2,181.75 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 4.89% 4.22% 4.72% 3.33% 6.11% 6.05% 4.77% 2.40% 0.05% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 1.88 2.05 1.34 1.56 1.51 1.00 0.95 0.92 0.74 0.65 0.70
Enterprise Value to Revenue (EV/Rev)		 0.24 0.31 0.20 0.22 0.22 0.16 0.17 0.15 0.13 0.13 0.14
Enterprise Value to EBITDA (EV/EBITDA)		 5.67 7.20 5.08 6.07 5.23 4.52 5.18 5.39 5.26 5.25 5.25
Enterprise Value to EBIT (EV/EBIT)		 7.25 9.42 7.03 8.93 7.31 6.82 8.16 9.46 11.96 13.18 12.16
Enterprise Value to NOPAT (EV/NOPAT)		 9.33 11.96 9.13 12.04 10.01 9.19 11.30 12.83 7.05 18.83 17.37
Enterprise Value to Operating Cash Flow (EV/OCF)		 2.50 5.13 3.86 4.65 7.73 5.85 25.43 27.06 6.50 10.51 5.66
Enterprise Value to Free Cash Flow (EV/FCFF)		 2.95 6.76 5.59 7.68 18.19 13.42 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.46 0.45 0.45 0.45 0.46 0.46 0.48 0.48 0.48 0.48 0.48
Long-Term Debt to Equity		 0.46 0.45 0.45 0.45 0.46 0.46 0.48 0.48 0.48 0.48 0.48
Financial Leverage		 -0.19 -0.21 -0.25 -0.32 -0.34 -0.26 -0.23 -0.29 -0.24 -0.14 -0.09
Leverage Ratio		 2.47 2.47 2.46 2.48 2.43 2.50 2.49 2.50 2.47 2.58 2.56
Compound Leverage Factor		 5.15 2.05 1.96 2.05 1.38 0.97 1.09 0.34 9.13 -0.64 1.40
Debt to Total Capital		 31.65% 31.04% 31.10% 31.01% 31.34% 31.71% 32.25% 32.24% 32.46% 32.54% 32.34%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 31.65% 31.04% 31.10% 31.01% 31.34% 31.71% 32.25% 32.24% 32.46% 32.54% 32.34%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 68.35% 68.96% 68.90% 68.99% 68.66% 68.29% 67.75% 67.76% 67.54% 67.46% 67.66%
Debt to EBITDA		 2.17 2.22 2.45 2.71 2.34 2.77 3.03 3.54 4.01 4.07 3.70
Net Debt to EBITDA		 -1.69 -1.41 -1.64 -2.13 -1.67 -1.44 -0.93 -1.59 -1.21 -0.30 -0.26
Long-Term Debt to EBITDA		 2.17 2.22 2.45 2.71 2.34 2.77 3.03 3.54 4.01 4.07 3.70
Debt to NOPAT		 3.58 3.68 4.41 5.38 4.48 5.64 6.62 8.42 5.38 14.58 12.25
Net Debt to NOPAT		 -2.78 -2.35 -2.95 -4.22 -3.20 -2.93 -2.04 -3.78 -1.62 -1.09 -0.87
Long-Term Debt to NOPAT		 3.58 3.68 4.41 5.38 4.48 5.64 6.62 8.42 5.38 14.58 12.25
Altman Z-Score		 3.82 3.84 3.61 3.58 3.61 3.30 3.38 3.37 3.28 3.16 3.25
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 5.13 4.71 4.88 4.58 4.85 4.16 4.55 4.60 4.66 3.90 4.01
Quick Ratio		 3.43 3.09 3.22 3.12 3.13 2.58 2.74 2.92 2.86 2.30 2.39
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 196 82 60 49 -20 -9.24 -65 -54 -95 -106 -58
Operating Cash Flow to CapEx		 897.83% -585.24% 567.67% 838.76% 92.70% -571.61% -278.53% 985.64% 1,135.19% -2,201.85% 468.79%
Free Cash Flow to Firm to Interest Expense		 0.00 17.80 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 -6.73 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 -7.88 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 2.07 1.97 1.92 1.85 1.90 1.82 1.86 1.85 1.89 1.84 1.89
Accounts Receivable Turnover		 13.07 10.44 10.63 10.27 13.00 10.41 10.67 10.79 13.31 10.40 10.12
Inventory Turnover		 6.30 6.52 6.81 6.98 7.04 6.39 6.61 7.27 7.34 6.53 6.61
Fixed Asset Turnover		 14.53 13.96 13.63 13.09 12.42 11.59 11.49 11.28 11.02 10.73 10.79
Accounts Payable Turnover		 16.86 14.59 13.58 12.66 15.01 12.80 13.87 14.07 16.32 12.34 13.83
Days Sales Outstanding (DSO)		 27.93 34.96 34.35 35.56 28.08 35.05 34.20 33.83 27.43 35.10 36.06
Days Inventory Outstanding (DIO)		 57.91 55.98 53.59 52.28 51.83 57.09 55.18 50.18 49.73 55.87 55.24
Days Payable Outstanding (DPO)		 21.65 25.02 26.87 28.82 24.31 28.52 26.33 25.94 22.36 29.59 26.38
Cash Conversion Cycle (CCC)		 64.18 65.92 61.07 59.01 55.59 63.63 63.05 58.07 54.80 61.38 64.92
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 406 466 455 424 436 482 530 490 528 593 600
Invested Capital Turnover		 6.34 6.17 6.33 6.72 7.01 6.19 5.98 6.45 6.13 5.53 5.32
Increase / (Decrease) in Invested Capital		 -177 -61 -42 -31 30 17 75 66 92 111 70
Enterprise Value (EV)		 765 955 609 660 659 482 505 452 389 383 421
Market Capitalization		 993 1,142 806 891 869 635 596 585 478 406 442
Book Value per Share		 $72.35 $75.41 $75.31 $76.90 $77.13 $76.69 $77.45 $78.94 $78.49 $78.25 $79.86
Tangible Book Value per Share		 $62.52 $65.59 $65.60 $67.14 $67.32 $66.89 $67.43 $68.88 $58.92 $59.05 $60.68
Total Capital		 928 947 947 950 942 932 917 919 914 912 919
Total Debt		 294 294 294 295 295 295 296 296 297 297 297
Total Long-Term Debt		 294 294 294 295 295 295 296 296 297 297 297
Net Debt		 -228 -187 -197 -232 -211 -154 -91 -133 -89 -22 -21
Capital Expenditures (CapEx)		 8.42 5.32 6.31 7.36 20 5.93 9.61 5.95 5.45 2.60 2.38
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 380 442 430 397 395 437 475 431 387 458 478
Debt-free Net Working Capital (DFNWC)		 902 924 921 924 900 886 862 860 773 777 797
Net Working Capital (NWC)		 902 924 921 924 900 886 862 860 773 777 797
Net Nonoperating Expense (NNE)		 37 3.51 3.61 1.77 3.83 4.45 5.54 10 6.28 6.59 5.35
Net Nonoperating Obligations (NNO)		 -228 -187 -197 -232 -211 -154 -91 -133 -89 -22 -21
Total Depreciation and Amortization (D&A)		 7.63 8.78 9.47 8.88 8.75 8.90 9.14 9.23 14 12 12
Debt-free, Cash-free Net Working Capital to Revenue		 12.12% 14.43% 14.25% 13.45% 13.37% 14.88% 16.12% 14.60% 13.11% 15.38% 15.89%
Debt-free Net Working Capital to Revenue		 28.75% 30.13% 30.53% 31.26% 30.49% 30.17% 29.24% 29.16% 26.17% 26.10% 26.46%
Net Working Capital to Revenue		 28.75% 30.13% 30.53% 31.26% 30.49% 30.17% 29.24% 29.16% 26.17% 26.10% 26.46%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($1.98) $2.02 $1.65 $1.88 $0.67 $0.33 $0.54 $0.20 ($1.05) ($0.18) $0.82
Adjusted Weighted Average Basic Shares Outstanding		 8.65M 8.66M 8.53M 8.38M 8.29M 8.02M 7.89M 7.87M 7.87M 7.78M 7.86M
Adjusted Diluted Earnings per Share		 ($1.96) $2.00 $1.65 $1.87 $0.67 $0.33 $0.54 $0.20 ($1.05) ($0.18) $0.81
Adjusted Weighted Average Diluted Shares Outstanding		 8.65M 8.66M 8.53M 8.38M 8.29M 8.02M 7.89M 7.87M 7.87M 7.78M 7.86M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 8.65M 8.66M 8.53M 8.38M 8.29M 8.02M 7.89M 7.87M 7.87M 7.78M 7.86M
Normalized Net Operating Profit after Tax (NOPAT)		 19 21 18 18 9.11 7.26 9.85 6.98 -2.27 5.13 12
Normalized NOPAT Margin		 2.67% 2.89% 2.34% 2.38% 1.28% 1.02% 1.26% 0.93% -0.32% 0.70% 1.44%
Pre Tax Income Margin		 -1.13% 3.17% 2.48% 2.89% 0.98% 0.58% 0.84% 0.18% -1.67% -0.25% 1.38%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 5.98 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 4.54 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 4.83 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 3.39 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 86.81% 0.00% 118.32% 144.00% 85.28% 156.92% 232.91% 380.58% 17,409.13% -639.76% -414.12%

Financials Breakdown Chart

Key Financial Trends

BlueLinx Holdings (NYSE:BXC) showed a meaningful improvement in the second quarter of 2026, although profitability remains below the levels seen earlier in the four-year period. Revenue increased to $814.1 million from $780.1 million in Q2 2025 and $731.1 million in Q1 2026. The company also returned to profitability, reporting net income of $6.4 million, or $0.81 per diluted share, compared with a $1.5 million loss, or negative $0.18 per share, in Q1.

Margins improved substantially in the latest quarter. Gross profit rose to $139.7 million, producing a gross margin of approximately 17.2%, compared with 15.3% in Q2 2025 and 15.9% in Q1 2026. Operating income increased to $20.6 million, versus $15.0 million a year earlier and $7.3 million in Q1. However, net income was still affected by approximately $9.4 million of net other expense, primarily interest-related costs.

The longer-term trend remains mixed. BlueLinx generated stronger quarterly earnings in 2023 and early 2024, including $24.5 million of net income in Q2 2023, $17.5 million in Q1 2024 and $16.0 million in Q3 2024. Results weakened during late 2024 and early 2025 before recovering in Q2 2026. This suggests that improved gross margins and revenue growth are encouraging, but the company has not yet returned to its earlier earnings power.

Cash flow also improved sequentially. Operating cash flow was positive at $11.2 million in Q2 2026, compared with negative $57.2 million in Q1 and negative $26.8 million in Q2 2025. Still, operating cash flow remains volatile and was well below the $58.6 million generated in Q3 2025 and the $61.8 million generated in Q4 2025. Working-capital movements were a $9.4 million use of cash in Q2, following a much larger $70.2 million use in Q1.

BlueLinx ended Q2 with $318.2 million of cash and equivalents, broadly stable with Q1 but down from $429.4 million in Q3 2025 and $526.3 million in Q3 2024. The balance sheet remains liquid, with approximately $1.06 billion of current assets against $264.9 million of current liabilities. Long-term debt was relatively stable at $297.1 million, but cash interest paid was $16.2 million during the quarter—more than twice reported net income—highlighting the pressure that financing costs place on shareholder returns.

  • Revenue momentum improved: Q2 2026 revenue increased approximately 4.4% year over year and 11.3% sequentially.
  • Gross-margin expansion: Gross margin improved to approximately 17.2%, the strongest level among the comparable Q2, Q1 and recent quarterly results provided.
  • Return to profitability: Net income improved from a $1.5 million loss in Q1 2026 to $6.4 million of profit in Q2, while diluted EPS rose to $0.81.
  • Operating cash flow recovered: Cash generated from operations improved to $11.2 million from negative $57.2 million in Q1 and negative $26.8 million a year earlier.
  • Strong short-term liquidity: Current assets were about four times current liabilities, giving BlueLinx flexibility to fund operations and manage seasonal working-capital needs.
  • Debt was broadly stable: Long-term debt remained near $297 million, but the benefit of stable borrowings is partly offset by substantial cash interest costs.
  • Share count declined over the longer term: Weighted average diluted shares fell to 7.9 million in Q2 2026 from 9.0 million in Q2 2023, although Q2 2026 shares were slightly higher than Q1 2026.
  • Interest expense remains a major constraint: Q2 cash interest paid of $16.2 million exceeded net income by a wide margin and reduced the conversion of operating profit into shareholder earnings.
  • Cash reserves have declined: Cash fell from $526.3 million in Q3 2024 to $318.2 million in Q2 2026, reflecting ongoing buybacks, investing spending and financing outflows.
  • Profitability remains below earlier peaks: Despite the Q2 recovery, net income and EPS remain well below the levels reported in several 2023 and 2024 quarters.
10/14/26 06:51 AM ETAI Generated. May Contain Errors.

BlueLinx Financials - Frequently Asked Questions

According to the most recent income statement we have on file, BlueLinx's financial year ends in January. Their financial year 2026 ended on January 3, 2026.

BlueLinx's net income appears to be on an upward trend, with a most recent value of $219 thousand in 2025, compared with -$11.58 million in 2015. The previous period was $53.12 million in 2024. View BlueLinx's forecast to see where analysts expect BlueLinx to go next.

BlueLinx's total operating income in 2025 was $32.48 million, based on the following breakdown:
  • Total Gross Profit: $451.63 million
  • Total Operating Expenses: $419.15 million

Over the last 10 years, BlueLinx's total revenue changed from $1.92 billion in 2015 to $2.95 billion in 2025, a change of 54.1%.

In the past 13 quarters, BlueLinx's cash and equivalents has ranged from $318.18 million in Q2 2026 to $526.28 million in Q3 2024, and is currently $318.18 million as of their latest financial filing in Q2 2026.

BlueLinx had total debt of $296.66 million at the end of 2025, a 0.5% increase from 2024, and a 22.8% decrease since 2015.

Over the last 10 years, BlueLinx's book value per share changed from -0.51 in 2015 to 78.49 in 2025.


Related Companies

Financial statements for NYSE:BXC last updated on 8/4/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Wall Street legend reveals his top AI stock before Oct. 20
Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock...
Chaikin Analytics | Sponsoredtc pixel
Trump's about to unleash his Midterm Weapon
Trump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...
Monument Traders Alliance | Sponsoredtc pixel
A Simple Guide to Options Trading While It's Still Free
A free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...
True Market Insiders | Sponsoredtc pixel
This AI fund posted a 34 percent annualized payout last month
One small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling ...
Investors Alley | Sponsoredtc pixel
Federal Reserve Reveals Disturbing New Plan To Control Your Money
Docket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on p...
Weiss Ratings | Sponsoredtc pixel
Buffett's Final Warning: "The Dollar Is Going to Hell"
In 2025, the dollar lost 12% in value. Real inflation hit 5%+. 12% + 5% = 17% purchasing power gone. And it's ...
Decentralized Masters | Sponsoredtc pixel
INSANE DRONE FOOTAGE
New drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...
Paradigm Press | Sponsoredtc pixel
Why Some AI Stocks Already Surged Over 300 Percent
Jason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run...
Brownstone Research | Sponsoredtc pixel